Metabolic Phenotypes and Chronic Kidney Disease: A Cross-Sectional Assessment of Patients from a Large Federally Qualified Health Center
- PMID: 33672432
- PMCID: PMC7926935
- DOI: 10.3390/life11020175
Metabolic Phenotypes and Chronic Kidney Disease: A Cross-Sectional Assessment of Patients from a Large Federally Qualified Health Center
Abstract
The purpose of this study is to determine if renal function varies by metabolic phenotype. A total of 9599 patients from a large Federally Qualified Health Center (FQHC) were included in the analysis. Metabolic health was classified as the absence of metabolic abnormalities defined by the National Cholesterol Education Program Adult Treatment Panel III criteria, excluding waist circumference. Obesity was defined as body mass index >30 kg/m2 and renal health as an estimated glomerular filtration rate (eGFR) >60 mL/min/1.73 m2. Linear and logistic regressions were used to analyze the data. The metabolically healthy overweight (MHO) phenotype had the highest eGFR (104.86 ± 28.76 mL/min/1.72 m2) and lowest unadjusted odds of chronic kidney disease (CKD) (OR = 0.46, 95%CI = 0.168, 1.267, p = 0.133), while the metabolically unhealthy normal weight (MUN) phenotype demonstrated the lowest eGFR (91.34 ± 33.28 mL/min/1.72 m2) and the highest unadjusted odds of CKD (OR = 3.63, p < 0.0001). After controlling for age, sex, and smoking status, the metabolically unhealthy obese (MUO) (OR = 1.80, 95%CI = 1.08, 3.00, p = 0.024) was the only phenotype with significantly higher odds of CKD as compared to the reference. We demonstrate that the metabolically unhealthy phenotypes have the highest odds of CKD compared to metabolically healthy individuals.
Keywords: chronic kidney disease; metabolic phenotypes; metabolic syndrome; obesity; renal disease.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance System—United States. [(accessed on 5 October 2020)]; Available online: http://www.cdc.gov/ckd.
-
- Centers for Disease Control and Prevention . Chronic Kidney Disease in the United States, 2019. US Department of Health and Human Services, Centers for Disease Control and Prevention; Atlanta, GA, USA: 2019.
-
- Hales C., Carroll M., Fryar C., Ogden C. Prevalence of Obesity among Adults and Youth: United States, 2017–2018. National Center for Health Statistics; Hyattsville, MD, USA: 2020.
-
- Kouvari M., Panagiotakos D.B., Yannakoulia M., Georgousopoulou E., Critselis E., Chrysohoou C., Tousoulis D., Pitsavos C. ATTICA Study Investigators Transition From Metabolically Benign to Metabolically Unhealthy Obesity and 10-Year Cardiovascular Disease Incidence: The ATTICA Cohort Study. Metabolism. 2019;93:18–24. doi: 10.1016/j.metabol.2019.01.003. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
